StockData
First Tracks Biotherapeutics, Inc. logo

First Tracks Biotherapeutics, Inc. (TRAX) stock

TRAXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 3, 2026
$43.57−2.99 (-6.42%)

Close on Nov 17, 2026Market cap $1.56BP/E –Yield –

First Tracks Biotherapeutics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

First Tracks Biotherapeutics's enterprise value was $1.62B on Nov 11, 2026.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.62B–

More First Tracks Biotherapeutics figures

See a number that looks wrong?